Connection

Klaus Überla to Drug Repositioning

Back to Details
This is a "connection" page, showing publications Klaus Überla has written about Drug Repositioning.
Klaus Überla
Connection Strength
0.057
Drug Repositioning
  1. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro. Viruses. 2020 12 05; 12(12).
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.